Literature DB >> 15170507

Mast cell tryptase, a still enigmatic enzyme.

L Fiorucci1, F Ascoli.   

Abstract

Tryptases constitute a subfamily of trypsin-like proteinases, stored in the mast cell secretory granules of all mammalian organisms. These enzymes are released along with other mediators into the extracellular medium upon mast cell activation/degranulation. Among the trypsin-like enzymes, tryptases are unique: they are present as active enzymes in the mast cell granules, but display activity only extracellularly, and have a specificity which is much more restricted than trypsin. Tryptases are mostly tetrameric, and in only few organisms (not in humans) are they inhibited by endogenous inhibitors in vitro. The enzymatic and molecular properties of tryptases are far better characterized that any of their plausible biological functions. On the basis of its structural and functional features it could be predicted that tryptase would not degrade a large number of proteins in vivo due to low accessibility to the tetramer central pore where the active sites face inwards. Although their biological function has not yet been clarified, tryptases seem to be involved in a number of mast cell-mediated allergic and inflammatory diseases. In particular, the involvement of tryptase in asthma, an inflammatory disease of the airways often caused by allergy, has been proposed. Here we review the present knowledge on the structure-function relationship of tryptases from different organisms, with special emphasis on human enzymes, and on their role in a variety of pathophysiological processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170507     DOI: 10.1007/s00018-004-3400-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  23 in total

Review 1.  Stem cell therapy in perspective.

Authors:  Bodo E Strauer; Ran Kornowski
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

2.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

Review 3.  [Surgical intramyocardial stem cell therapy for chronic ischemic heart failure].

Authors:  Alexander Kaminski; Peter Donndorf; Christian Klopsch; Gustav Steinhoff
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

4.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

Authors:  Birgit Assmus; Volker Schächinger; Claudius Teupe; Martina Britten; Ralf Lehmann; Natascha Döbert; Frank Grünwald; Alexandra Aicher; Carmen Urbich; Hans Martin; Dieter Hoelzer; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

5.  The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study.

Authors:  Bodo-Eckehard Strauer; Muhammad Yousef; Christiana M Schannwell
Journal:  Eur J Heart Fail       Date:  2010-07       Impact factor: 15.534

6.  Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

Authors:  Bodo E Strauer; Michael Brehm; Tobias Zeus; Thomas Bartsch; Christina Schannwell; Christine Antke; Rüdiger V Sorg; Gesine Kögler; Peter Wernet; Hans-Wilhelm Müller; Matthias Köstering
Journal:  J Am Coll Cardiol       Date:  2005-11-01       Impact factor: 24.094

7.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Authors:  Ketil Lunde; Svein Solheim; Svend Aakhus; Harald Arnesen; Michael Abdelnoor; Torstein Egeland; Knut Endresen; Arnfinn Ilebekk; Arild Mangschau; Jan G Fjeld; Hans Jørgen Smith; Eli Taraldsrud; Haakon Kiil Grøgaard; Reidar Bjørnerheim; Magne Brekke; Carl Müller; Einar Hopp; Asgrimur Ragnarsson; Jan E Brinchmann; Kolbjørn Forfang
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 8.  Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

Authors:  Michael J Lipinski; Giuseppe G L Biondi-Zoccai; Antonio Abbate; Reena Khianey; Imad Sheiban; Jozef Bartunek; Marc Vanderheyden; Hyo-Soo Kim; Hyun-Jae Kang; Bodo E Strauer; George W Vetrovec
Journal:  J Am Coll Cardiol       Date:  2007-10-15       Impact factor: 24.094

9.  Evidence for cardiomyocyte renewal in humans.

Authors:  Olaf Bergmann; Ratan D Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

10.  The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.

Authors:  Muhammad Yousef; Christiana Mira Schannwell; Mathias Köstering; Tobias Zeus; Michael Brehm; Bodo Eckehard Strauer
Journal:  J Am Coll Cardiol       Date:  2009-06-16       Impact factor: 24.094

View more
  8 in total

1.  Allosteric control of βII-tryptase by a redox active disulfide bond.

Authors:  Kristina M Cook; H Patrick McNeil; Philip J Hogg
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

2.  A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-Tryptase.

Authors:  Sarah F Giardina; Douglas S Werner; Maneesh Pingle; Donald E Bergstrom; Lee D Arnold; Francis Barany
Journal:  Pharmacology       Date:  2018-08-22       Impact factor: 2.547

3.  Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression.

Authors:  Devandir Antonio de Souza; Vanina Danuza Toso; Maria Rita de Cássia Campos; Vanessa Soares Lara; Constance Oliver; Maria Célia Jamur
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

4.  Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain.

Authors:  Santiago Cal; Juan R Peinado; María Llamazares; Víctor Quesada; Angela Moncada-Pazos; Cecilia Garabaya; Carlos López-Otín
Journal:  BMC Biochem       Date:  2006-03-27       Impact factor: 4.059

Review 5.  Mast cell glycosaminoglycans.

Authors:  B Mulloy; R Lever; C P Page
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

Review 6.  Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress.

Authors:  Maria Sole Chimenti; Flavia Sunzini; Laura Fiorucci; Elisabetta Botti; Giulia Lavinia Fonti; Paola Conigliaro; Paola Triggianese; Luisa Costa; Francesco Caso; Alessandro Giunta; Maria Esposito; Luca Bianchi; Roberto Santucci; Roberto Perricone
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

7.  Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis.

Authors:  Simone Serrao; Davide Firinu; Alessandra Olianas; Margherita Deidda; Cristina Contini; Federica Iavarone; M Teresa Sanna; Mozhgan Boroumand; Francisco Amado; Massimo Castagnola; Irene Messana; Stefano Del Giacco; Barbara Manconi; Tiziana Cabras
Journal:  J Proteome Res       Date:  2020-07-06       Impact factor: 4.466

8.  Mast Cell-Derived Tryptase in Geographic Atrophy.

Authors:  D Scott McLeod; Imran Bhutto; Malia M Edwards; Manasee Gedam; Rajkumar Baldeosingh; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-11-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.